Decrease in the frequency of treatment for patent ductus arteriosus after implementation of consensus guidelines: a 15-year experience

Lara Pavageau, Luc P. Brion, Charles R. Rosenfeld, L. Steven Brown, Claudio Ramaciotti, P. Jeannette Burchfield, Mambarambath A. Jaleel

Research output: Contribution to journalArticle

Abstract

Background: Patent ductus arteriosus (PDA) management varies widely among neonatologists. Local problem: Lack of institution-specific evidence-based guidelines for therapeutic closure of PDA. Methods: Quality improvement project among infants <30 weeks gestational age (GA) designed to determine whether the odds of therapy for closing the PDA, adjusted for GA, decreased after implementing evidence-based guidelines. Intervention: Implementation of guidelines with conservative approach to PDA management. Results: The frequency of PDA treatment decreased from 446/1125 (40%) in Epoch 1 to 96/482 (20%) in Epoch 2. PDA treatment was more frequent in neonates 23–26 weeks GA than those of 27–29 weeks GA (43% vs. 28%, respectively). Among 542 infants receiving indomethacin for PDA, 25% had subsequent ligation; the odds of ligation after indomethacin were lower in neonates 27–29 weeks GA and decreased during Epoch 2. Conclusions: The frequency of medical and surgical treatment for therapeutic closure of PDA decreased after implementing evidence-based treatment guidelines.

Original languageEnglish (US)
Pages (from-to)1569-1576
Number of pages8
JournalJournal of Perinatology
Volume39
Issue number11
DOIs
StatePublished - Nov 1 2019

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Decrease in the frequency of treatment for patent ductus arteriosus after implementation of consensus guidelines: a 15-year experience'. Together they form a unique fingerprint.

  • Cite this